Searchable abstracts of presentations at key conferences in endocrinology

ea0056p127 | Endocrine tumours and neoplasia | ECE2018

Adrenocortical cancer – the effectiveness of mitotane therapy depending on the time of therapy and the therapeutic dose

Stepinski Kamil , Jurecka-Lubieniecka Beata , Michalik Barbara , Szpak-Ulczok Sylwia , Soczomski Przemyslaw , Jarzeb Barbara

Introduction: Mitotane-o’p-DDD belongs to insecticides (DDT pesticide contamination), it is the only drug registered by the FDA in treatment in adrenocortical carcinoma (ACC). Treatment effect is controled by mitotane concentration in the blood.Aim: The aim of the study is to evaluate the effectiveness of mitotane treatment in patients with adrenocortical cancer.Material and methods: We retrospectively reviewed data on ACC pat...